Intuitive Surgical Announces First Quarter Earnings

Go back to Intuitive Surgical Announces First Quarter Earnings

Intuitive Surgical (ISRG) PT Raised to $870 at Barclays

April 19, 2017 9:59 AM EDT

Barclays raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $870.00 (from $830.00) while maintaining a Overweight rating.... More

Intuitive Surgical (ISRG) PT Raised to $870 at Canaccord Genuity

April 19, 2017 9:40 AM EDT

Canaccord Genuity raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $870.00 (from $800.00) while maintaining a Buy rating. Management increased 2017 procedure growth expectations to a range of 12-14% (previously 9-12%), with the update driven by solid continued adoption in US general surgery... More

Intuitive Surgical (ISRG) PT Raised to $917 at Citi; 'Raising the Bar Again'

April 19, 2017 8:25 AM EDT

Citi raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $917.00 (from $820.00) while maintaining a Buy rating following strong results.

Analyst Amit Hazan said "This was as solid a quarter weve seen from ISRG since its heyday, with +18% procedure growth far... More

Intuitive Surgical (ISRG) PT Raised to $850 at Stifel

April 19, 2017 7:09 AM EDT

Stifel raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $850.00 (from $800.00) while maintaining a Buy rating following "extremely robust 1Q results highlighted by meaningfully better-than-expected procedure growth (18% vs. 11-12% expectation), strong system sales despite a new trade-up offer, and above-expectation gross margins (72% vs. 69.5%... More

Intuitive Surgical (ISRG) PT Raised to $785 at Evercore ISI

April 19, 2017 6:23 AM EDT

Evercore ISI raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $785.00 (from $750.00) while maintaining a In Line rating following strong results.

What analyst Vijay Kumar liked:

Announced X launch - instruments on the X system (CE Mark in 2Q) are compatible... More